Q4 2020 Neogenomics Inc Earnings Call Transcript
Good morning, ladies and gentlemen, and welcome to the NeoGenomics Quarter 4 and Full Year 2020 Earnings Call. (Operator Instructions)
It is now my pleasure to turn the floor over to your host, Doug VanOort, Chairman and CEO of NeoGenomics. Sir, the floor is yours.
Well, thank you, Paul. Good morning. I'd like to welcome everyone to NeoGenomics' fourth quarter 2020 conference call.
Joining me for this call are a number of management team members from our Fort Myers headquarters, including Kathryn McKenzie, our Chief Financial Officer; Rob Shovlin, President of our Clinical Division; Bill Bonello, President of our Informatics Division; Doug Brown, our Chief Strategy and Corporate Development Officer; and Charlie Eidson, our Manager of Investor Relations. Joining on the call via phone from California is Dr. Larry Weiss, our Chief Medical Officer and Director of R&D; and George Cardoza, President of our Pharma Services Division.
Also joining us this morning is Lynn Tetrault
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |